Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients

Inclusion Criteria

• •Adult patients of both genders
• •Myocardial Infarction diagnosis
• •Dyslipidemia diagnosis
• •The first injection of inclisiran no later than 14 ± 5 days after the STEMI/non-STEMI
• •LDL-C \> 5 mmol/L (statin-naive patients) or LDL-C \> 2.5 mmol/L (on the basis of statin MTD) at the time of hospitalization or no target LDL-C level (\> 1.4 mmol/L or no LDL-C level decrease by 50% on statin MTD + ezetimibe)
• •Signed Informed Consent Form (ICF)